- Androgen deprivation therapy of prostate cancer and cardiovascular morbidity +12019 | First Faculty of Medicine
- Androgen deprivation therapy - a standard in management of prostate cancer2022 | First Faculty of Medicine
- Denosumab for Men Receiving Androgen Deprivation Therapy for Prostate Cancer2009 | Third Faculty of Medicine
- Responder analysis of the effects of denosumab on bone mineral density in men receiving androgen deprivation therapy for prostate cancer2012 | Third Faculty of Medicine
- Neoadjuvant hormonal therapy in prostate cancer - impact of PSA level before radiotherapy2013 | First Faculty of Medicine
- Advances in nonsurgical treatment of locally advanced and high-risk prostate cancer2018 | Third Faculty of Medicine
- Gonadal suppression alters axillary steroid secretions in men, but does that affect olfactory social signaling?2021 | Faculty of Science
- Prognostic factors in metastatic prostate cancer2023 | First Faculty of Medicine
- Triptorelin in the treatment of prostate cancer2009 | Second Faculty of Medicine
- Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer2017 | Faculty of Medicine in Hradec Králové
- 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)2023 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Enzalutamide monotherapy in hormone-naive prostate cancer: primary analysis of an open-label, single-arm, phase 2 study2014 | First Faculty of Medicine, Third Faculty of Medicine
- Metastatic prostate cancer - changes in treatment strategy2019 | First Faculty of Medicine
- Current treatment options for metastatic castration-resistant prostate cancer2018 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové, Faculty of Physical Education and Sport
- Report of University Hospital Hradec Králové to the clinical trial protocol No: 212082PCR3011Publication without faculty affiliation
- New treatment options in hormone-sensitive prostate cancer +12019 | First Faculty of Medicine
- Follow-up and treatment of patients following radical prostatectomy with positive surgical margins2017 | Second Faculty of Medicine
- Options of Chemotherapy in the Treatment of Prostate Cancer2017 | First Faculty of Medicine
- Polyneuropathic Pain Therapy with a Patient Suffering from Generalized Castrate Resistant Prostate Cancer - Clinical Case Report2013 | Faculty of Medicine in Pilsen
- Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society2020 | Faculty of Medicine in Hradec Králové
- Therapy of prostate cancer in elderly patients2022 | First Faculty of Medicine
- Current treatment of non-metastatic castration-refractory prostate cancer2021 | First Faculty of Medicine